Browse

Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier

Cited 23 time in Web of Science Cited 26 time in Scopus
Authors
Yang, Rui; Li, Wei-Wei; Hoang, Bang H; Kim, Hansoo; Banerjee, Debabrata; Kheradpour, Albert; Healey, John H; Meyers, Paul A; Bertino, Joseph R; Gorlick, Richard
Issue Date
2008-05-03
Publisher
BioMed Central
Citation
BMC Cancer 8:124-132
Keywords
Antineoplastic Agents/administration & dosageBreast Neoplasms/drug therapy/enzymology/genetics/pathologyCell Line, Tumor*DNA MethylationDown-RegulationDrug Resistance, Neoplasm/drug effectsDrug TherapyFemaleGene Expression Regulation, NeoplasticHumansMembrane Transport Proteins/*biosynthesis/*geneticsMethotrexate/administration & dosageOsteosarcoma/drug therapy/enzymology/genetics/pathology*Promoter Regions, GeneticRNA, Messenger/biosynthesis/*genetics
Abstract
BACKGROUND: Methotrexate (MTX) uptake is mediated by the reduced folate carrier (RFC). Defective drug uptake in association with decreased RFC expression is a common mechanism of MTX resistance in many tumor types. Heavy promoter methylation was previously identified as a basis for the complete silencing of RFC in MDA-MB-231 breast cancer cells, its role and prevalence in RFC transcription regulation are, however, not widely studied. METHODS: In the current study, RFC promoter methylation was assessed using methylation specific PCR in a panel of malignant cell lines (n = 8), including MDA-MB-231, and M805, a MTX resistant cell line directly established from the specimen of a patient with malignant fibrohistocytoma, whom received multiple doses of MTX. A quantitative approach of real-time PCR for measuring the extent of RFC promoter methylation was developed, and was validated by direct bisulfite genomic sequencing. RFC mRNA levels were determined by quantitative real-time RT-PCR and were related to the extent of promoter methylation in these cell lines. RESULTS: A partial promoter methylation and RFC mRNA down-regulation were observed in M805. Using the quantitative approach, a reverse correlation (correlation coefficient = -0.59, p < 0.05) was identified between the promoter methylation and RFC mRNA levels in this a panel of malignant cell lines. CONCLUSION: This study further suggests that promoter methylation is a potential basis for MTX resistance. The quantitative correlation identified in this study implies that promoter methylation is possibly a mechanism involved in the fine regulation of RFC transcription.
ISSN
1471-2407 (Electronic)
Language
English
URI
https://hdl.handle.net/10371/62512
DOI
https://doi.org/10.1186/1471-2407-8-124
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Orthopedic Surgery (정형외과학전공)Journal Papers (저널논문_정형외과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse